Overview

This trial is active, not recruiting.

Condition colorectal cancer
Treatments booklet, audio cd, video with non-moving images, video with animated images, questionnaires
Sponsor M.D. Anderson Cancer Center
Collaborator Foundation for Informed Medical Decision Making
Start date November 2012
End date November 2017
Trial size 201 participants
Trial identifier NCT02151032, 0619-1, 2011-0632

Summary

The goal of this research study is to compare how people who are 45-75 years old respond to 3 different versions of a program about screening tests for colorectal cancer. Researchers want to use this study as part of a long-term project to learn the best ways to communicate health information to patients.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case control
Time perspective prospective
Arm
Participants read the booklet about colorectal cancer screening tests, and listen to an audio CD that will narrate the booklet. Questionnaire completion before and after viewing the program.
booklet Pamphlet
Participants read a booklet about colorectal cancer screening tests.
audio cd
Participants listen to an audio CD that will narrate the colorectal cancer screening tests booklet.
questionnaires Surveys
Questionnaire completion before and after viewing the program.
Participants watch a video with non-moving images about colorectal cancer screening tests on an iPad. Questionnaire completion before and after viewing the program.
video with non-moving images
Participants watch a video with non-moving images about colorectal cancer screening tests on an iPad.
questionnaires Surveys
Questionnaire completion before and after viewing the program.
Participants watch a video with animated images about colorectal cancer screening tests on an iPad. Questionnaire completion before and after viewing the program.
video with animated images
Participants watch a video with animated images about colorectal cancer screening tests on an iPad.
questionnaires Surveys
Questionnaire completion before and after viewing the program.

Primary Outcomes

Measure
Gist and Verbatim Knowledge for a Colorectal Cancer Screening Program
time frame: 1 day

Eligibility Criteria

Male or female participants from 45 years up to 75 years old.

Inclusion Criteria: 1. Men and women 45 to 75 years of age. 2. Participant must speak English. Exclusion Criteria: 1) Self-reported diagnosis of colon cancer.

Additional Information

Official title Using Multimedia Approaches to Communicate Probabilities in Patient Decision Aids for Low-Literacy Populations: Randomized Trial
Principal investigator Robert Volk, PHD
Description If you agree to take part in this study, you will be randomly assigned (as in a roll of dice) to 1 of 3 study groups. Neither you nor the study staff will be able to choose which group you will be in: - If you are in Group 1, you will read a booklet about colorectal cancer screening tests. While reading the booklet, you will also listen to an audio CD that will narrate the booklet. - If you are in Group 2, you will watch a video with non-moving images about colorectal cancer screening tests on an iPad. - If you are in Group 3, you will watch a video with animated images about colorectal cancer screening tests on an iPad. You will complete questionnaires before and after viewing the program that will contain questions about: - Your age and what language you speak - Your math and reading comprehension - Your knowledge of colorectal cancer and colorectal cancer screening - Your thoughts about colorectal cancer screening - Your opinions about this study, and - How well you understand the booklet/video you view as part of this study It will take about 1 hour to complete all the questionnaires. In total, the study will take about 1 ½ to 2 hours to complete. After you have completed the questionnaires, your participation in the study will be over. This is an investigational study. Up to 201 people will take part in this multicenter study. Up to 67 will be enrolled at MD Anderson.
Trial information was received from ClinicalTrials.gov and was last updated in June 2016.
Information provided to ClinicalTrials.gov by M.D. Anderson Cancer Center.